Professor Nadia A Rosenthal

Nadia Rosenthal holds a Chair in Cardiovascular Science at Imperial College London, where she started in 2005 as Scientific Director of the  Magdi Yacoub Institute, and is Head of the Heart Science Centre/Section within NHLI.

She maintains her current appointments as Senior Scientist and Head of the Mouse Biology Unit at European Molecular Laboratory [EMBL] in Rome, Italy (since 2001), Founding Director of the Australian Regenerative Medicine Institute at Monash University in Melbourne, Australia (since 2007), Scientific Head of EMBL Australia (since 2009) and an NH&MRC Australia Fellowship (since 2010).

Born in the US, Professor Rosenthal obtained her PhD in 1981 from Harvard Medical School and trained as a postdoctoral fellow at NIH, then directed a biomedical research laboratory at Harvard Medical School, and served for a decade at the New England Journal of Medicine as editor of the Molecular Medicine series. She is an EMBO member, with numerous awards and honors including the Ferrari-Soave Prize in Cell Biology and a Doctor Honoris Causa from the Pierre and Marie Curie University in Paris. She participates on numerous Advisory Boards and Committees including the Scientific Advisory Board-Keystone Symposia, the Scientific Advisory Board-Centre for Molecular Medicine, Vienna and Scientific Advisory Board-Institute of Molecular Biology and Biotechnology, Heraklion, Crete. In addition, Professor Rosenthal is the Founding Editor of Disease Models and Mechanisms (2007) and serves on Editorial Boards of Developmental Biology, Developmental Dynamics and Rejuvenation Research.

Professor Rosenthal’s research uses mammalian genetics to explore the embryonic development of heart and skeletal muscle and the regeneration of adult tissues. In the last decade her focus on the biology of insulin-like growth factors has led to significant advances in novel cell-based therapies for muscle ageing and heart disease. She is a global leader in the use of targeted mutagenesis in mice to investigate muscle development, disease, and repair, e.g., through studies of the IGF-1, calcineurin, NFkB and Notch pathways, and is a participant in EUCOMM, the European Conditional Mouse Mutagenesis Program.